Jennifer Walker-Journey

5062 posts

Jennifer Walker-Journey is a professional writer whose 20-year career spans from newspapers and magazines to Ezines and business blogs. Her primary focus is corporate and business writing, though she relishes any opportunity to write features. In her limited free time, Jennifer strives to finish the novel she is writing. She lives in Birmingham with her husband, Rick, and their insatiably curious son, Truman.

Family of Tony Gwynn files wrongful death lawsuit against tobacco industry

Tony Gwynn - Flickr

The family of baseball Hall of Famer Tony Gwynn is suing Altria Group Inc, formerly known as Philip Morris, claiming the tobacco giant and others in the industry manipulated Gwynn to become addicted to smokeless tobacco that ultimately led to his death from salivary gland cancer. Gwynn was the kind of athlete parents were proud of their kids to look up to. He got along well with his teammates, and didn’t drink or smoke. Like many baseball players at the time, he used smokeless tobacco, or dip, and his choice product was Skoal. Gwynn was under the impression dip was not as ... Read More

Dietary supplement maker slapped with $40 million judgment over false claims allegations

supplement - Jack3d

Lunada Biomedical Inc. has accepted a nearly $40 million judgment to settle false advertising claims brought by the Federal Trade Commission (FTC) involving its dietary supplement Amberen, and to stop promoting the product as “clinically proven” to relieve symptoms of menopause and trim belly fat. The FTC had filed the lawsuit last year, claiming Lunada had generated $60 million in sales of Amberen by running national radio and television advertisements that claimed the product “restores hormonal balance naturally, so the weight can just fall right off. Even that stubborn belly fat,” and that Amberen was “the ONLY product on the market today ... Read More

$2.5 million verdict over Risperdal side effects stands


A $2.5 million jury verdict against Johnson & Johnson’s Janssen Pharmaceuticals involving claims the company’s antipsychotic drug Risperdal caused an autistic boy to grow female breasts will stand, a Philadelphia judge ruled. Philadelphia County Court of Common Pleas Judge Ramy I. Djerassi rejected the drug company’s bid for a new trial based on claims that allowing a new expert in the bellwether trial had left Janssen’s attorneys unprepared for the new testimony. The drug company also argued that the $2.5 million verdict was excessive because it relied on the plaintiff’s mother’s accounts of her son’s experiences after growing breasts. Djerassi ... Read More

Amendment to restrict sales of dietary supplements on military bases withdrawn

supplement - Jack3d

An amendment to the National Defense Authorization Act (NDAA) requiring dietary supplements sold on military bases to first be vetted for purity was withdrawn, but the amendment may be brought up again when the bill comes to the Senate, Nutra Ingredients-USA reported. The amendment was proposed by Sen. Richard Blumenthal (D-CT) in the Senate Armed Services Committee meeting and would have required dietary supplements sold on a military base commissary or retail store operating on a military be verified by an independent third party “for recognized public standards of identity, purity, strength, and composition, and adherence to related process standards.” “We ... Read More

FDA warns of serious risks with oral anti-fungal treatment


Oral tablets of the anti-fungal medication ketoconazole should not be used to treat skin and nail fungal infections because the drug carries a risk for serious liver damage, adrenal gland problems and harmful interactions with other medications, the Food and Drug Administration (FDA) warned in a Safety Alert. In 2013, the label of ketoconazole tablets was updated to reflect these serious risks and to remove the indications for the treatment of skin and nail fungal infections. But since then, the FDA has found that the oral version of ketoconazole continues to be prescribed for these types of conditions. In the ... Read More

Opioid-related hospitalizations, infections, costs increased sharply

World of Pain

The impact of the prescription drug epidemic is often told in the number of lives lost by overdoses from misuse and abuse of power painkillers known as opioids. But a new report tells the story from a different perspective. Opioid-related hospitalizations and infections have sharply risen in recent years, and inpatient charges have nearly quadrupled. “The growing problem of opioid abuse in the United States has been well documented, but our study is the first of its kind to quantify serious infections related to opioid abuse and their impact on the U.S. hospital system and on health care costs,” said ... Read More

Janssen, Bayer face Xarelto wrongful death lawsuit


The daughter of an Ohio man has filed a wrongful death lawsuit against the makers of the blood thinner Xarelto. Michelle Clark, on behalf of her deceased father, Clarence Mason, filed the complaint in the U.S. District Court for the Eastern District of Louisiana. The lawsuit names Johnson & Johnson’s Janssen Pharmaceuticals, Bayer Healthcare, and their related companies. According to the complaint, Clarence took Xarelto as prescribed from Dec. 26, 2013, until August 2014. In April 2014, the man suffered gastrointestinal bleeding, which caused him pain and suffering, disability, disfigurement, mental anguish, and loss of the ability to enjoy life. He ... Read More

JAMA: containment system does not eliminate cancer spread risk with power morcellators


A new containment system designed to isolate uterine tissue during hysterectomies and myomectomies (uterine fibroid removal) during power morecellator procedures has not been proven to reduce the risk of spreading cancerous tissue, which could quickly upstage previously undiagnosed cancer and worsen the odds of survival. A report published this month in the Journal of the American Medical Association (JAMA), alerted medical professionals that while the PneumoLiner containment system effectively contains morcellatored tissue, the manufacturer, Advanced Surgical Concepts, must warn clinicians and patients that there is still a risk of cancer spread when the containment system is used. “This new device ... Read More

Anti-seizure medication Lyrica linked to major birth defects


Lyrica, a prescription mediation used to treat nerve and muscle pain, may cause major birth defects to babies whose mothers use the drug during pregnancy, according to a study published in Neurology, the medical journal of the American Academy of Neurology. Lyrica contains the active drug ingredient pregabalin and is used to treat conditions such as epilepsy, fibromyalgia and generalized anxiety disorder. The prospective cohort study involved data from 164 women from seven countries who took Lyrica during pregnancy and 656 pregnant women who did not take the drug or any similar medications. Researchers followed up with the women or their ... Read More

FDA computer glitch mislabeled information in Essure adverse event reports


The Food and Drug Administration (FDA) relies on physicians, patients and caregivers to report adverse events caused by medications or medical devices. These reports can help identify public health issues and can lead to products being recalled or withdrawn from the market, or being labeled with a black box warning. While adverse event reports from all parties are welcome, those from medical professionals can provide more crucial data that can be helpful for regulators when conducting a safety review of a drug or medical device. But an investigation by the NBC New York I-Team has found that many adverse event ... Read More